Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA
NRG Oncology
NRG Oncology
Memorial Sloan Kettering Cancer Center
Universität des Saarlandes
Washington University School of Medicine
Institut Claudius Regaud
M.D. Anderson Cancer Center
Guangxi Medical University
Rutgers, The State University of New Jersey
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Groupe Oncologie Radiotherapie Tete et Cou
Zhejiang Provincial People's Hospital
GERCOR - Multidisciplinary Oncology Cooperative Group
University of Chicago
University of Chicago
City of Hope Medical Center
Sun Yat-sen University
Chengdu University of Traditional Chinese Medicine
Sun Yat-sen University
Hospital of Stomatology, Wuhan University
Institute of Oncology Ljubljana
University of Chicago
University of Chicago
German Society for Pediatric Oncology and Hematology GPOH gGmbH
University Medical Center Groningen
Rutgers, The State University of New Jersey
Shanghai Jiao Tong University School of Medicine
University of Chicago
Shanghai Jiao Tong University School of Medicine
Beijing Tongren Hospital
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
First Affiliated Hospital of Zhejiang University
Zhejiang University
Assistance Publique Hopitaux De Marseille
Sun Yat-sen University
University of California, San Francisco
Groupe Oncologie Radiotherapie Tete et Cou
Groupe Oncologie Radiotherapie Tete et Cou
Sun Yat-sen University
Arbeitsgemeinschaft medikamentoese Tumortherapie
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Abramson Cancer Center at Penn Medicine
Massachusetts General Hospital
Sun Yat-sen University
Sun Yat-sen University
Ruijin Hospital
Sun Yat-sen University
UNICANCER
Washington University School of Medicine
Sun Yat-sen University